继2025年高速增长后,2026年中国医药“出海”热度持续攀升。行业数据显示,今年1月我国创新药BD(商务拓展)合作交易总额达346亿美元,首付款超30亿美元,交出亮眼的开年答卷。 伴随中国创新药的国际化进程不断深化,药企“出海”版图持续扩容,目的地也更趋多元。在欧美成熟市场之外,中东、东南亚、拉美等地区正快速崛起为新兴热门市场。 而当前,据央视报道,当地时间3月4日,美国与以色列对伊朗发起的...
Source Link继2025年高速增长后,2026年中国医药“出海”热度持续攀升。行业数据显示,今年1月我国创新药BD(商务拓展)合作交易总额达346亿美元,首付款超30亿美元,交出亮眼的开年答卷。 伴随中国创新药的国际化进程不断深化,药企“出海”版图持续扩容,目的地也更趋多元。在欧美成熟市场之外,中东、东南亚、拉美等地区正快速崛起为新兴热门市场。 而当前,据央视报道,当地时间3月4日,美国与以色列对伊朗发起的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.